Basics of I.V. Therapy - B. Braun
Plasma Volume Replacement (PVR)
Water is the dominant substance of the human body. Its water content depends on age and sex. For a young adult, body water constitutes about 60% of body weight and is distributed between intracellular and extracellular space in a ratio of about 2 : 1. The differences in composition are large, with potassium, magnesium and phosphate dominating in the intracellular space and sodium, calcium and chloride in the extracellular space (table 1).
Table 1: Composition and characteristics of the main fluid compartments of the human body
Extracellular space
Intracellular space
Parameter Plasma Interstitial fluid
Sodium (mmol/l) 141 143 10
Potassium (mmol/l) 4.0 4.0 155
Calcium (mmol/l) 2.5 1.4 < 0.001
Magnesium (mmol/l) 1.0 0.7 15
Chloride (mmol/l) 103 115 8.0
Phosphate (mmol/l) 1.0 1.0 65
Bicarbonate (mmol/l) 25 28 10
pH 7.4 7.4 7.2
Osmolality (mOsm/l) 280 280 280
COP (mm Hg) 25 4.0 -
Within the extracellular space the two most important compartments are interstitial space and intravascular space with a relative size of 3 : 1 to each other. Their electrolyte composition is very similar; however, colloid osmotic pressure (COP) is much higher in the intravascular space. This difference is crucial in order to maintain the volume of the intravascular space and results from the protein in plasma. Out of the 80 g/l plasma protein about 50 g/l are albumin, but this accounts for approximately 80% of the colloid-osmotic pressure.

For the supply of tissues with oxygen and nutrients it is vital to maintain the circulation and in this regard the maintenance of intravascular volume is the single most important parameter.


A reduction of the circulating blood volume is called hypovolaemia and can be the consequence of a blood or plasma loss (absolute hypovolaemia) or a vasodilation (relative hypovalaemia). Hypovolaemia increases the sympathetic nervous system activity and activates the renin-angiotensin-aldosterone system. In the adult a satisfactory compensation can only be reached, however, if the lack of volume in the circulation does not surpass 10-15% of the normal volume. Hypovolaemia above this level can no longer be compensated for through these mechanisms alone and will result in a sustained fall of blood pressure and increased heart rate. A reduced cardiac preload as a consequence of diminished venous return reduces stroke volume and hence cardiac output. The ensuing disturbance of macro and microcirculation leads to hypoxia which itself induces endothelial damage with activation of blood coagulation and diminishing blood flow, especially in the microcirculation. The reduced blood flow allows rouleau formation of the red blood cells, further deteriorating the blood flow through the capillaries. The net result is a failure of the circulatory system to maintain adequate organ perfusion and oxygenation, organ failures and death.

The prevention of this development is based on early and adequate plasma volume replacement. In general terms, the following solutions are suitable for volume replacement:
  • Isotonic electrolyte solutions, also called crystalloids (e.g. Ringer´s solution, Hartmann´s solution or NaCl 0.9% solution)
  • Colloidal volume replacement solutions containing a synthetic macromolecular substance as active ingredient in a crystalloid solution ( e.g. dextran, gelatine and hydroxyethyl starch solutions)
  • Colloidal volume replacement solutions based on natural colloids (e.g. human albumin and plasma protein solutions)
Because of the absence of a suitable macromolecular substance, crystalloid solutions will go into the whole of the extracellular space after infusion. Only about one fourth to one fifth of the volume infused will stay in the circulation, while the bulk will end up in the interstitial space. The absence of a macromolecular substance also leads to a rapid elimination of the crystalloid solution through kidneys, giving it a volume effect for only approximately 20-30 min. Therefore, while crystalloid solutions are indispensable for the correction of interstitial fluid losses, their exclusive use for vascular volume replacement is not possible if hypovolaemia is too severe. Excessive administration of crystalloids will induce severe interstitial oedema and may lead to pulmonary oedema and tissue hypoxia.
  top

Privacy Policy | Terms of use | Imprint
Subsidiary Companies | Therapies & Themes | Country Websites
Copyright © 2010 B. Braun Melsungen AG
Volume Replacement Therapy
PDF Documents

Haemodynamic parameters related to blood pressure
(250 kb)
Haemodynamic parameters related to cardiac function
(347kb)
Parameters related to oxygen
(840 kb)